When patients present to your clinical practice with early relapsed/refractory multiple myeloma (R/R MM), do you have the confidence to take on the task of selecting and sequencing the optimal treatment regimen based on patient, disease, and treatment-related factors? Enhance your knowledge with this interactive case-based challenge, accompanied by evidence-based commentary from a MM expert oncologist, to support you in applying your clinical reasoning skills to individualized early R/R MM treatment selection.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/effectively-individualizing-early-r-r-mm-treatment-selection-sequencing
- Start Date: 2024-10-30 05:00:00
- End Date: 2024-10-30 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Sanofi S.A. - Amount: 19875.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology
Subscribe
Login
0 Comments
Oldest